Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population
NAGIOS: RODERIC FUNCIONANDO

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

DSpace Repository

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Show full item record

View       (799.2Kb)

    
Asukai, Yumi; Valladares, Amparo; Camps Herrero, Carlos; Wood, Eifiona; Taipale, Kaisa; Arellano, Jorge; Cassinello, Alejo; Sacristán, José Antonio; Dilla, Tatiana
This document is a artículoDate2010

Este documento está disponible también en : http://hdl.handle.net/10550/44818

    BMC Cancer Vol. 10 pp. 26-26

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

Statistics